Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2016-03-04
Original SEC Filing: Click here

---

Webplus: CBPO/20160304/8-K/2_EX-1.1/000.htm SEC Original: v433220_ex1-1.htm
Execution Version CHINA BIOLOGIC PRODUCTS, INC. 3,500,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT March 1, 2016 March 1, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares Common Stock

---

---

Webplus: CBPO/20160304/8-K/3_EX-1.2/000.htm SEC Original: v433220_ex1-2.htm
Execution Version CHINA BIOLOGIC PRODUCTS, INC. 3,870,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) AMENDED AND RESTATED UNDERWRITING AGREEMENT March 2, 2016 March 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule

---

---

Webplus: CBPO/20160304/8-K/4_EX-5.1/000.htm SEC Original: v433220_ex5-1.htm
4 March China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act We have examined the registration statement on Form S-3 (No. 333-204761) (the “ Common Stock Preferred Stock Prospectus Prospectus Supplement Selling Stockholders Shares Underwriting Agreement We understand that 3,870,000 shares of Common Stock are to be sold by certain stockholders

---

---

Webplus: CBPO/20160304/8-K/5_EX-99.1/000.htm SEC Original: v433220_ex99-1.htm
China Biologic Announces Secondary Offering of Common Stock BEIJING, China – March 1, 2016 The shares to be sold in this offering represent approximately 13.2 percent of the Company’s current outstanding shares of common stock. Morgan Stanley & Co. International plc is acting as the sole underwriter for the offering. prospectus@morganstanley.com This press release shall not constitute an offer to

---

---

Webplus: CBPO/20160304/8-K/6_EX-99.2/000.htm SEC Original: v433220_ex99-2.htm
China Biologic Announces Pricing of Secondary Offering of Common Stock BEIJING, China – March 2, 2016 China Biologic will not sell any shares of common stock in the offering and will not receive any proceeds from the sale of the Purchased Shares or the Additional Shares. prospectus@morganstanley.com This press release shall not constitute an offer to sell or the solicitation

---

---

Webplus: CBPO/20160304/8-K/1/000.htm SEC Original: v433220_8k.htm

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2016-03-04CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125